Holen Sie sich die Stockscreener-App
248.95
7.48%
17.33
Handel nachbörslich:
248.95
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$231.62
Offen:
$235.37
24-Stunden-Volumen:
1.48M
Relative Volume:
1.83
Marktkapitalisierung:
$17.91B
Einnahmen:
$2.96B
Nettoeinkommen (Verlust:
$487.70M
KGV:
37.29
EPS:
6.6758
Netto-Cashflow:
$344.00M
1W Leistung:
+7.71%
1M Leistung:
-11.35%
6M Leistung:
+4.92%
1J Leistung:
-24.67%
1-Tages-Spanne:
$233.50
$249.64
1-Wochen-Bereich:
$228.00
$249.64
52-Wochen-Spanne:
$187.43
$332.47
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
248.95 | 16.66B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
488.15 | 169.16B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
210.05 | 58.84B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
271.63 | 38.90B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.30 | 38.45B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.83 | 38.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
WST: Integrated syringe system accelerates development and simplifies compliance for pharma teams - TradingView
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? - Finviz
West Pharma Sets February Earnings Reveal as Investors Await 2025 Results - MyChesCo
Selecting A Prefillable Syringe System With Confidence - Bioprocess Online
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 7 - Med Device Online
West Pharmaceutical Services drives innovation in cancer treatment packaging - Traders Union
West Pharmaceutical Services Inc (WST) Shares Up 4.04% on Feb 4 - GuruFocus
NovaPure® Syringe Plungers eBook: Chapter 2: Component Design And Manufacture - Med Device Online
Evercore ISI Lowers Price Target for West Pharmaceutical Services (WST) | WST Stock News - GuruFocus
West Pharmaceutical Services (BIT:1WST) Price Target Decreased by 11.92% to 278.11 - Nasdaq
Truist Financial Corp Has $7.64 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside - DirectorsTalk Interviews
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
Volume Report: Is West Pharmaceutical Services Inc part of any major index2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New York State Common Retirement Fund Has $23.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Valuation Check After Recent Share Price Pressure - Yahoo Finance
Published on: 2026-01-31 17:32:53 - Mfd.ru
Assessing West Pharmaceutical Services (WST) After A 32% One-Year Share Price Pullback - Sahm
West Pharmaceutical Services Inc (WST) Shares Gap Down to $225.5 on Jan 30 - GuruFocus
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Is West Pharmaceutical (WST) Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat? - Sahm
West to Host Fourth-Quarter and Full-Year 2025 Conference Call - BioSpace
Kinston marks anniversary of West Pharmaceutical Services explosion - WCTI
Is West Pharmaceutical Services Inc. a good ESG investmentPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru
West Pharmaceutical Services, Inc. $WST Shares Sold by Bank of New York Mellon Corp - MarketBeat
Process Safety Quiz: Dust Explosions and Fires - ChemistryViews
Prefilled Syringe Barrels Market Set for Dynamic Development - openPR.com
West to sell SmartDose 3.5mL system to AbbVie in $112.5M deal - MSN
West Pharmaceutical Services taps Robert McMahon as CFO - MSN
Ex-Dividend Reminder: West Pharmaceutical Services, Heritage Financial and Entegris - Nasdaq
Assessing West Pharmaceutical (WST) Valuation After Bullish Earnings Outlook And Demand Strength - Sahm
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? - Benzinga
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - MyChesCo
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Profit Review: What is Know Labs Incs market positionJuly 2025 Earnings & Weekly High Return Stock Forecasts - baoquankhu1.vn
Is West Pharmaceutical Services Stock Built to Withstand More Downside? - Trefis
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio - Sahm
Analysis Recap: Can AROW grow without external funding2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack - sharewise.com
West Pharmaceutical Services Becomes Oversold (WST) - Nasdaq
Bull Run: Is West Pharmaceutical Services Inc trading at a discountM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? - Yahoo Finance
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Market Outlook: Is West Pharmaceutical Services Inc stock showing strong momentumEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn
Performance Recap: Whats the outlook for West Pharmaceutical Services Incs sector2025 Historical Comparison & Fast Entry High Yield Tips - baoquankhu1.vn
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - yourwyominglink.com
All you need to know about West Pharmaceutical (WST) rating upgrade to strong buy - MSN
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):